Fayez Sarofim & Co Sells 26,145 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Fayez Sarofim & Co lowered its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 17.1% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 126,534 shares of the pharmacy operator's stock after selling 26,145 shares during the period. Fayez Sarofim & Co's holdings in Walgreens Boots Alliance were worth $1,181,000 as of its most recent filing with the SEC.

Other large investors have also modified their holdings of the company. MetLife Investment Management LLC increased its stake in shares of Walgreens Boots Alliance by 1.9% in the fourth quarter. MetLife Investment Management LLC now owns 189,908 shares of the pharmacy operator's stock worth $1,772,000 after acquiring an additional 3,610 shares during the last quarter. Norinchukin Bank The increased its position in Walgreens Boots Alliance by 12.0% in the 4th quarter. Norinchukin Bank The now owns 34,039 shares of the pharmacy operator's stock worth $318,000 after purchasing an additional 3,660 shares during the last quarter. Ossiam raised its stake in shares of Walgreens Boots Alliance by 52.0% during the 4th quarter. Ossiam now owns 115,662 shares of the pharmacy operator's stock worth $1,079,000 after purchasing an additional 39,578 shares in the last quarter. BI Asset Management Fondsmaeglerselskab A S acquired a new stake in shares of Walgreens Boots Alliance during the 4th quarter valued at about $946,000. Finally, Dimensional Fund Advisors LP grew its stake in shares of Walgreens Boots Alliance by 17.6% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,823,924 shares of the pharmacy operator's stock valued at $17,016,000 after buying an additional 272,895 shares in the last quarter. 58.59% of the stock is owned by institutional investors.

Walgreens Boots Alliance Price Performance

Shares of Walgreens Boots Alliance stock traded down $0.02 during trading on Friday, hitting $11.01. 6,349,910 shares of the company's stock traded hands, compared to its average volume of 21,025,070. The company has a market cap of $9.52 billion, a PE ratio of -1.08, a PEG ratio of 1.31 and a beta of 0.67. The firm's fifty day moving average price is $10.95 and its 200 day moving average price is $10.19. Walgreens Boots Alliance, Inc. has a twelve month low of $8.08 and a twelve month high of $18.83. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last released its quarterly earnings data on Tuesday, April 8th. The pharmacy operator reported $0.63 earnings per share for the quarter, beating analysts' consensus estimates of $0.53 by $0.10. The company had revenue of $38.59 billion for the quarter, compared to the consensus estimate of $37.90 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. During the same period in the previous year, the business earned $1.20 earnings per share. The company's quarterly revenue was up 4.1% on a year-over-year basis. Analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on WBA shares. Truist Financial cut their target price on Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating on the stock in a report on Friday, January 31st. Bank of America increased their price target on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an "underperform" rating in a report on Monday, January 13th. Wolfe Research raised shares of Walgreens Boots Alliance to a "hold" rating in a report on Monday, February 24th. Deutsche Bank Aktiengesellschaft downgraded shares of Walgreens Boots Alliance from a "hold" rating to a "sell" rating and dropped their target price for the stock from $11.00 to $9.00 in a report on Friday, February 28th. Finally, StockNews.com assumed coverage on shares of Walgreens Boots Alliance in a research report on Saturday, April 19th. They set a "hold" rating for the company. Four analysts have rated the stock with a sell rating, seven have issued a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, Walgreens Boots Alliance has a consensus rating of "Hold" and an average target price of $10.59.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.